Application

EFFIENT

DAIICHI SANKYO COMPANY, LIMITED

Trademark/Service Mark Application, Principal Register

PTO Form 1478 (Rev 6/2005)
OMB No. 0651-0009 (Exp xx/xx/xxxx)

Trademark/Service Mark Application, Principal Register

Serial Number: 78883436
Filing Date: 05/15/2006


The table below presents the data as entered.

Input Field
Entered
MARK SECTION
MARK EFFIENT
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT EFFIENT
MARK STATEMENT The mark consists of standard characters, without claim to any particular font, style, size, or color.
OWNER SECTION
NAME Eli Lilly and Company
STREET Lilly Corporate Center
CITY Indianapolis
STATE Indiana
ZIP/POSTAL CODE 46285
COUNTRY United States
PHONE 317 651 1346
FAX 317 276 1919
EMAIL XXXX
AUTHORIZED EMAIL COMMUNICATION Yes
LEGAL ENTITY SECTION
TYPE CORPORATION
STATE/COUNTRY OF INCORPORATION Indiana
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
DESCRIPTION Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of blood disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dermatological disorders, diabetes, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, immunological, bacterial, viral and fungal disorders, infectious diseases, inflammation and inflammatory diseases, musculoskeletal diseases and disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, sepsis, urological disorders and sleep disorders.
FILING BASIS Section 1(b)
ADDITIONAL STATEMENTS SECTION
MISCELLANEOUS STATEMENT The mark is a coined, non-dictionary word with no English translation.
SIGNATURE SECTION
SIGNATURE /blongbottom/
SIGNATORY NAME Bruce W. Longbottom
SIGNATORY DATE 05/15/2006
SIGNATORY POSITION Associate General Counsel
PAYMENT SECTION
NUMBER OF CLASSES 1
NUMBER OF CLASSES PAID 1
SUBTOTAL AMOUNT 325
TOTAL AMOUNT 325
PAYMENT METHOD DA
ATTORNEY
NAME Bruce W. Longbottom
FIRM NAME Eli Lilly and Company
STREET Lilly Corporate Center
CITY Indianapolis
STATE Indiana
ZIP/POSTAL CODE 46254
COUNTRY United States
PHONE 317 651 1346
FAX 317 276 1919
EMAIL trademarks@lilly.com
AUTHORIZED EMAIL COMMUNICATION Yes
OTHER APPOINTED ATTORNEY(S) Robert E. Lee, Jr., Douglas K. Norman, Lawrence T. Welch
CORRESPONDENCE SECTION
NAME Bruce W. Longbottom
FIRM NAME Eli Lilly and Company
STREET Lilly Corporate Center
CITY Indianapolis
STATE Indiana
ZIP/POSTAL CODE 46254
COUNTRY United States
PHONE 317 651 1346
FAX 317 276 1919
EMAIL trademarks@lilly.com
AUTHORIZED EMAIL COMMUNICATION Yes
FILING INFORMATION
SUBMIT DATE Mon May 15 13:35:25 EDT 2006
TEAS STAMP USPTO/BAS-XXXXXXX-2006051
5133525186649-78883436-20
0e1c16edf3648cafeb81fa9bf
186-DA-1778-2006051511370
3488531



PTO Form 1478 (Rev 6/2005)
OMB No. 0651-0009 (Exp xx/xx/xxxx)


Trademark/Service Mark Application, Principal Register

Serial Number: 78883436
Filing Date: 05/15/2006


To the Commissioner for Trademarks:

MARK: (Standard Characters, see mark)

The mark consists of standard characters, without claim to any particular font, style, size, or color.

The literal element of the mark consists of EFFIENT.

The applicant, Eli Lilly and Company, a corporation of Indiana, residing at Lilly Corporate Center, Indianapolis, Indiana, United States, 46285, requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended.

Intent to Use: The applicant has a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or services. (15 U.S.C. Section 1051(b)).

       International Class 005: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of blood disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dermatological disorders, diabetes, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, immunological, bacterial, viral and fungal disorders, infectious diseases, inflammation and inflammatory diseases, musculoskeletal diseases and disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, sepsis, urological disorders and sleep disorders.

The mark is a coined, non-dictionary word with no English translation.

The applicant hereby appoints Bruce W. Longbottom and Robert E. Lee, Jr., Douglas K. Norman, Lawrence T. Welch of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, United States, 46254 to submit this application on behalf of the applicant.

The USPTO is authorized to communicate with the applicant or its representative at the following email address: trademarks@lilly.com.

A fee payment in the amount of $325 will be submitted with the application, representing payment for 1 class(es).

Declaration

The undersigned, being hereby warned that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements, and the like, may jeopardize the validity of the application or any resulting registration, declares that he/she is properly authorized to execute this application on behalf of the applicant; he/she believes the applicant to be the owner of the trademark/service mark sought to be registered, or, if the application is being filed under 15 U.S.C. Section 1051(b), he/she believes applicant to be entitled to use such mark in commerce; to the best of his/her knowledge and belief no other person, firm, corporation, or association has the right to use the mark in commerce, either in the identical form thereof or in such near resemblance thereto as to be likely, when used on or in connection with the goods/services of such other person, to cause confusion, or to cause mistake, or to deceive; and that all statements made of his/her own knowledge are true; and that all statements made on information and belief are believed to be true.



Signature: /blongbottom/   Date: 05/15/2006
Signatory's Name: Bruce W. Longbottom
Signatory's Position: Associate General Counsel


Mailing Address:
     Bruce W. Longbottom
     Lilly Corporate Center
     Indianapolis, Indiana 46254

RAM Sale Number: 1778
RAM Accounting Date: 05/15/2006

Serial Number: 78883436
Internet Transmission Date: Mon May 15 13:35:25 EDT 2006
TEAS Stamp: USPTO/BAS-XXXXXXX-20060515133525186649-7
8883436-200e1c16edf3648cafeb81fa9bf186-D
A-1778-20060515113703488531

Application [inode/x-empty]